Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JOHNSON & JOHNSON Director's Dealing 2022

Jan 13, 2022

29750_dirs_2022-01-13_d58837a1-a932-4af4-9d6d-1b2a8601d5c9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2022-01-03

Reporting Person: Hait William (See Remarks)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 223158.0000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Options (Right to Buy) $90.4400 2024-02-09 Common Stock (59397.0000) Direct
Employee Stock Options (Right to Buy) $100.0600 2025-02-09 Common Stock (51484.0000) Direct
Employee Stock Options (Right to Buy) $101.8700 2026-02-08 Common Stock (54923.0000) Direct
Employee Stock Options (Right to Buy) $115.6700 2027-02-13 Common Stock (41097.0000) Direct
Employee Stock Options (Right to Buy) $129.5100 2028-02-11 Common Stock (37289.0000) Direct
Employee Stock Options (Right to Buy) $131.9400 2029-02-11 Common Stock (37911.0000) Direct
Employee Stock Options (Right to Buy) $151.4100 2030-02-10 Common Stock (49315.0000) Direct
Employee Stock Options (Right to Buy) $164.6200 2031-02-08 Common Stock (33593.0000) Direct
Restricted Share Units $ Common Stock (3059.0000) Direct
Restricted Share Units $ Common Stock (3856.0000) Direct
Restricted Share Units $ Common Stock (7790.0000) Direct

Footnotes

F1: Vested and exercisable on the third anniversary of the date of the grant.

F2: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.